Funding & Businessbiotechstartup fundingdrug repurposing
Biossil raises $70M to revive failed drugs
|
6.9
Biossil exits stealth with $70 million USD to give failed medicines a second chance. The Toronto-based biotech startup launched publicly to focus on rescuing previously unsuccessful drug candidates. It counts OpenAI, Founders Fund, and Staircase Ventures as backers.
Scoring Rationale
A notable mid-stage funding event with prominent investors, important for those tracking biotech funding and AI-related investment trends.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsFree Career Roadmaps8 PATHS
Step-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Data Analyst
Explore all career paths $95K
Data Scientist$130K
ML Engineer$155K
AI Engineer$160K
Data Engineer$140K
Analytics Eng.$140K
MLOps Engineer$160K
Quant Analyst$175K
